| __timestamp | Bio-Techne Corporation | Vertex Pharmaceuticals Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 106352000 | 60987000 |
| Thursday, January 1, 2015 | 144969000 | 125542000 |
| Friday, January 1, 2016 | 162364000 | 210460000 |
| Sunday, January 1, 2017 | 188462000 | 275119000 |
| Monday, January 1, 2018 | 210850000 | 409539000 |
| Tuesday, January 1, 2019 | 240515000 | 547758000 |
| Wednesday, January 1, 2020 | 255497000 | 736300000 |
| Friday, January 1, 2021 | 298182000 | 904200000 |
| Saturday, January 1, 2022 | 349103000 | 1080300000 |
| Sunday, January 1, 2023 | 366887000 | 1262200000 |
| Monday, January 1, 2024 | 389335000 | 1530500000 |
Unlocking the unknown
In the ever-evolving landscape of biotechnology, understanding the cost dynamics is crucial. Over the past decade, Vertex Pharmaceuticals Incorporated and Bio-Techne Corporation have shown distinct trends in their cost of revenue. From 2014 to 2023, Bio-Techne's cost of revenue surged by approximately 266%, reflecting its strategic investments and expansion. In contrast, Vertex Pharmaceuticals exhibited a staggering increase of over 1,900% during the same period, underscoring its aggressive growth and market penetration strategies.
Interestingly, while Bio-Techne's cost of revenue consistently rose each year, Vertex's data for 2024 remains elusive, hinting at potential strategic shifts or reporting delays. This analysis not only highlights the financial trajectories of these biotech giants but also offers insights into their operational efficiencies and market strategies. As the biotech sector continues to grow, these trends provide valuable foresight into future industry dynamics.
Comparing Cost of Revenue Efficiency: Johnson & Johnson vs Bio-Techne Corporation
Amgen Inc. vs Bio-Techne Corporation: Efficiency in Cost of Revenue Explored
Cost Insights: Breaking Down Gilead Sciences, Inc. and Bio-Techne Corporation's Expenses
Cost of Revenue Comparison: Vertex Pharmaceuticals Incorporated vs Dr. Reddy's Laboratories Limited
Cost Insights: Breaking Down Vertex Pharmaceuticals Incorporated and Alkermes plc's Expenses
Cost of Revenue Comparison: Vertex Pharmaceuticals Incorporated vs Supernus Pharmaceuticals, Inc.
Vertex Pharmaceuticals Incorporated vs Wave Life Sciences Ltd.: Efficiency in Cost of Revenue Explored
United Therapeutics Corporation vs Bio-Techne Corporation: Efficiency in Cost of Revenue Explored
Cost of Revenue Trends: Bio-Techne Corporation vs Walgreens Boots Alliance, Inc.
Bio-Techne Corporation vs Amneal Pharmaceuticals, Inc.: Efficiency in Cost of Revenue Explored
Bio-Techne Corporation vs Geron Corporation: Efficiency in Cost of Revenue Explored
Analyzing Cost of Revenue: Bio-Techne Corporation and Viridian Therapeutics, Inc.